Major histocompatibility complex class II (MHC II) molecules are central to adaptive immunity, presenting peptides derived from extracellular proteins to CD4+ T helper cells. Biosynthesis begins in ...
ROS are key players in the immune system's response to infection and cancer, influencing how the body identifies and fights these threats. A balanced level of ROS supports healthy immune function, but ...
To activate T cells, DCs take up, process, and present antigens as part of major histocompatibility complexes (MHCs) that interact with T cell receptors. Therefore, Curtis and her team set out to ...
CD8 + cytotoxic T lymphocytes (CTLs) serve as central effectors in cancer immunotherapy by directly eliminating tumor cells. However, current clinical therapies face significant limitations. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results